CHAPTER 1. INTRODUCTION

1.1. RESEARCH OBJECTIVE

1.2. SCOPE OF THE STUDY

1.3. DEFINITION

CHAPTER 2. RESEARCH METHODOLOGY (PREMIUM INSIGHTS)

2.1. RESEARCH APPROACH

2.2. DATA SOURCES

2.3. ASSUMPTIONS & LIMITATIONS

CHAPTER 3. EXECUTIVE SUMMARY

3.1. MARKET SNAPSHOT

CHAPTER 4. MARKET VARIABLES AND SCOPE 

4.1. INTRODUCTION

4.2. MARKET CLASSIFICATION AND SCOPE

4.3. INDUSTRY VALUE CHAIN ANALYSIS

4.3.1. RAW MATERIAL PROCUREMENT ANALYSIS 

4.3.2. SALES AND DISTRIBUTION CHANNEL ANALYSIS

4.3.3. DOWNSTREAM BUYER ANALYSIS

CHAPTER 5. COVID 19 IMPACT ON PEPTIDE SYNTHESIS MARKET 

5.1. COVID-19 LANDSCAPE: PEPTIDE SYNTHESIS INDUSTRY IMPACT

5.2. COVID 19 - IMPACT ASSESSMENT FOR THE INDUSTRY

5.3. COVID 19 IMPACT: GLOBAL MAJOR GOVERNMENT POLICY

5.4. MARKET TRENDS AND OPPORTUNITIES IN THE COVID-19 LANDSCAPE

CHAPTER 6. MARKET DYNAMICS ANALYSIS AND TRENDS

6.1. MARKET DYNAMICS

6.1.1. MARKET DRIVERS

6.1.2. MARKET RESTRAINTS

6.1.3. MARKET OPPORTUNITIES

6.2. PORTER’S FIVE FORCES ANALYSIS

6.2.1. BARGAINING POWER OF SUPPLIERS

6.2.2. BARGAINING POWER OF BUYERS

6.2.3. THREAT OF SUBSTITUTE

6.2.4. THREAT OF NEW ENTRANTS

6.2.5. DEGREE OF COMPETITION

CHAPTER 7. COMPETITIVE LANDSCAPE

7.1.1. COMPANY MARKET SHARE/POSITIONING ANALYSIS

7.1.2. KEY STRATEGIES ADOPTED BY PLAYERS

7.1.3. VENDOR LANDSCAPE

7.1.3.1. LIST OF SUPPLIERS

7.1.3.2. LIST OF BUYERS

CHAPTER 8. GLOBAL PEPTIDE SYNTHESIS MARKET, BY PRODUCT

8.1. PEPTIDE SYNTHESIS MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

8.1.1. REAGENTS & CONSUMABLES

8.1.1.1. MARKET REVENUE AND VOLUME FORECAST

8.1.2. EQUIPMENT

8.1.2.1. MARKET REVENUE AND VOLUME FORECAST

8.1.3. SERVICES

8.1.3.1. MARKET REVENUE AND VOLUME FORECAST

CHAPTER 9. GLOBAL PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY

9.1. PEPTIDE SYNTHESIS MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

9.1.1. LIQUID PHASE PEPTIDE SYNTHESIS (LPPS)

9.1.1.1. MARKET REVENUE AND VOLUME FORECAST

9.1.2. SOLID PHASE PEPTIDE SYNTHESIS (SPPS)

9.1.2.1. MARKET REVENUE AND VOLUME FORECAST

9.1.3. HYBRID TECHNOLOGY

9.1.3.1. MARKET REVENUE AND VOLUME FORECAST

CHAPTER 10. GLOBAL PEPTIDE SYNTHESIS MARKET, BY APPLICATION 

10.1. PEPTIDE SYNTHESIS MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

10.1.1. THERAPEUTICS

10.1.1.1. MARKET REVENUE AND VOLUME FORECAST

10.1.2. DIAGNOSIS

10.1.2.1. MARKET REVENUE AND VOLUME FORECAST

10.1.3. RESEARCH

10.1.3.1. MARKET REVENUE AND VOLUME FORECAST

CHAPTER 11. GLOBAL PEPTIDE SYNTHESIS MARKET, BY END-USE 

11.1. PEPTIDE SYNTHESIS MARKET REVENUE AND VOLUME FORECAST, BY END-USE

11.1.1. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

11.1.1.1. MARKET REVENUE AND VOLUME FORECAST

11.1.2. CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATION/CONTRACT RESEARCH ORGANIZATION

11.1.2.1. MARKET REVENUE AND VOLUME FORECAST

11.1.3. ACADEMIC RESEARCH & INSTITUTES

11.1.3.1. MARKET REVENUE AND VOLUME FORECAST

CHAPTER 12. GLOBAL PEPTIDE SYNTHESIS MARKET, REGIONAL ESTIMATES AND TREND FORECAST

12.1. NORTH AMERICA

12.1.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.1.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.1.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.1.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.1.5. U.S.

12.1.5.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.1.5.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.1.5.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.1.5.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.1.6. REST OF NORTH AMERICA

12.1.6.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.1.6.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.1.6.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.1.6.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.2. EUROPE

12.2.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.2.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.2.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.2.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.2.5. UK

12.2.5.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.2.5.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.2.5.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.2.5.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.2.6. GERMANY

12.2.6.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.2.6.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.2.6.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.2.6.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.2.7. FRANCE

12.2.7.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.2.7.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.2.7.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.2.7.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.2.8. REST OF EUROPE

12.2.8.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.2.8.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.2.8.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.2.8.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.3. APAC

12.3.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.3.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.3.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.3.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.3.5. INDIA

12.3.5.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.3.5.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.3.5.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.3.5.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.3.6. CHINA

12.3.6.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.3.6.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.3.6.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.3.6.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.3.7. JAPAN

12.3.7.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.3.7.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.3.7.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.3.7.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.3.8. REST OF APAC

12.3.8.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.3.8.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.3.8.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.3.8.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.4. MEA

12.4.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.4.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.4.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.4.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.4.5. GCC

12.4.5.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.4.5.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.4.5.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.4.5.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.4.6. NORTH AFRICA

12.4.6.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.4.6.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.4.6.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.4.6.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.4.7. SOUTH AFRICA

12.4.7.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.4.7.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.4.7.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.4.7.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.4.8. REST OF MEA

12.4.8.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.4.8.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.4.8.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.4.8.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.5. LATIN AMERICA

12.5.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.5.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.5.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.5.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.5.5. BRAZIL

12.5.5.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.5.5.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.5.5.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.5.5.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

12.5.6. REST OF LATAM

12.5.6.1. MARKET REVENUE AND VOLUME FORECAST, BY PRODUCT

12.5.6.2. MARKET REVENUE AND VOLUME FORECAST, BY TECHNOLOGY

12.5.6.3. MARKET REVENUE AND VOLUME FORECAST, BY APPLICATION

12.5.6.4. MARKET REVENUE AND VOLUME FORECAST, BY END-USE

CHAPTER 13. COMPANY PROFILES

13.1. AAPPTEC PEPTIDES

13.1.1. COMPANY OVERVIEW

13.1.2. PRODUCT OFFERINGS

13.1.3. FINANCIAL PERFORMANCE

13.1.4. RECENT INITIATIVES

13.2. ANASPEC

13.2.1. COMPANY OVERVIEW

13.2.2. PRODUCT OFFERINGS

13.2.3. FINANCIAL PERFORMANCE

13.2.4. RECENT INITIATIVES

13.3. ARAGEN LIFE SCIENCES

13.3.1. COMPANY OVERVIEW

13.3.2. PRODUCT OFFERINGS

13.3.3. FINANCIAL PERFORMANCE

13.3.4. RECENT INITIATIVES

13.4. AURIGENE PHARMACEUTICAL SERVICES

13.4.1. COMPANY OVERVIEW

13.4.2. PRODUCT OFFERINGS

13.4.3. FINANCIAL PERFORMANCE

13.4.4. RECENT INITIATIVES

13.5. BACHEM HOLDING

13.5.1. COMPANY OVERVIEW

13.5.2. PRODUCT OFFERINGS

13.5.3. FINANCIAL PERFORMANCE

13.5.4. RECENT INITIATIVES

13.6. BIOMATIK

13.6.1. COMPANY OVERVIEW

13.6.2. PRODUCT OFFERINGS

13.6.3. FINANCIAL PERFORMANCE

13.6.4. RECENT INITIATIVES

13.7. BIO-SYNTHESIS, INC.

13.7.1. COMPANY OVERVIEW

13.7.2. PRODUCT OFFERINGS

13.7.3. FINANCIAL PERFORMANCE

13.7.4. RECENT INITIATIVES

13.8. CPC SCIENTIFIC

13.8.1. COMPANY OVERVIEW

13.8.2. PRODUCT OFFERINGS

13.8.3. FINANCIAL PERFORMANCE

13.8.4. RECENT INITIATIVES

13.9. GENSCRIPT BIOTECH

13.9.1. COMPANY OVERVIEW

13.9.2. PRODUCT OFFERINGS

13.9.3. FINANCIAL PERFORMANCE

13.9.4. RECENT INITIATIVES

13.10. LIFETEIN LLC

13.10.1. COMPANY OVERVIEW

13.10.2. PRODUCT OFFERINGS

13.10.3. FINANCIAL PERFORMANCE

13.10.4. RECENT INITIATIVES

13.11. PROTEOGENIX

13.11.1. COMPANY OVERVIEW

13.11.2. PRODUCT OFFERINGS

13.11.3. FINANCIAL PERFORMANCE

13.11.4. RECENT INITIATIVES

13.12. SIGMA ALDRICH

13.12.1. COMPANY OVERVIEW

13.12.2. PRODUCT OFFERINGS

13.12.3. FINANCIAL PERFORMANCE

13.12.4. RECENT INITIATIVES

13.13. THERMO FISHER SCIENTIFIC

13.13.1. COMPANY OVERVIEW

13.13.2. PRODUCT OFFERINGS

13.13.3. FINANCIAL PERFORMANCE

13.13.4. RECENT INITIATIVES

13.14. USV INDIA

13.14.1. COMPANY OVERVIEW

13.14.2. PRODUCT OFFERINGS

13.14.3. FINANCIAL PERFORMANCE

13.10.4. RECENT INITIATIVES

CHAPTER 14. RESEARCH METHODOLOGY

14.1. PRIMARY RESEARCH

14.2. SECONDARY RESEARCH

14.3. ASSUMPTIONS

CHAPTER 15. APPENDIX

15.1. ABOUT US

15.2. GLOSSARY OF TERMS